NCT06761742Completed
Development of AI Model for Renal Tumor Diagnosis Using CT and Lab Tests
An Artificial Intelligence Model for Accurate Diagnosis of Renal Tumors Based on Multi-phase Contrast-enhanced CT and Laboratory Tests: A Model Development and Multi-center Evaluation Study
Source: ClinicalTrials.gov · Last updated 7 Jan 2025
Brief summary (registry, in English)
This multi-center retrospective study aims to develop a multimodal artificial intelligence diagnostic model using preoperative contrast-enhanced CT images and routine laboratory parameters from patients with renal tumors. The model is designed to assist clinicians in accurately predicting the pathological subtypes of renal tumors preoperatively, enabling detailed diagnoses and advancing precision medicine.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1922 (actual)
- First submitted
- 30 Dec 2024
- Start date
- 1 Jan 2024
- Primary completion date
- 1 Dec 2024
- Lead sponsor
- RenJi Hospital
- Diseases
- Kidney cancer, Childhood cancers
- NCT number
- NCT06761742
What you commit to
- Study type: Observational
- Participants enrolled: 1922
- From 1 Jan 2024 to the primary completion date, 1 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Lab values
- A time interval of more than three months between imaging or laboratory testing and pathological diagnosis.
Other
- Incomplete CT data or poor image quality that affects diagnostic analysis.
- Patients diagnosed with fat-rich renal angiomyolipoma (AML).
- Pathological diagnosis indicating the coexistence of two or more pathological types of renal tumors.
Who the study is looking for
- Underwent renal tumor resection with a complete postoperative pathological report, and the pathological diagnosis is one of the following types: clear cell renal cell carcinoma, papillary renal cell carcinoma, chromophobe renal cell carcinoma, renal angiomyolipoma, or renal oncocytoma.
- Complete and available four-phase contrast-enhanced CT scans prior to surgery.
- Complete and available routine laboratory test results prior to surgery.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shanghai Jiaotong University School of Medicine, Renji Hospital Coordinator of this site? Confirm its status | Shanghai | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.